HKI10311129, novel antibiotic, method for producing the same and the use thereof

US7557091B2 · kind B2 · utility

Assignee

• Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. Hans-Knöll-Institut · DE

Inventors

• Ute Moellmann · Jena, DE
• Kerstin Herold · Jena, DE
• Martin Roth · Jena, DE
• Ingrid Groth · Jena, DE
• Friedrich Gollmick · Jena, DE
• Udo Graefe · Jena, DE

Key dates

• Filing date: Feb 2, 2005
• Grant date: Jul 7, 2009
• Expiry date: Sep 1, 2026

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P31/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to the novel antibiotic HKI10311129 which has a molecular weight of 1113 and the summation formula C56H75NO22. The invention also relates to a method for producing said antibiotic using the microorganism Streptomyces spec. DSM 13059, and to the use thereof as an antibacterial substance which is especially effective against infections with Gram positive bacteria, especially antibiotic-resistant germs.